Patients’ priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia

Annabelle Southa MRC Clinical Trials Unit at UCL, UCL, London, UKCorrespondence[email protected]

Parveen Dhesia MRC Clinical Trials Unit at UCL, UCL, London, UK

Conor D. Tweeda MRC Clinical Trials Unit at UCL, UCL, London, UK

Suzanne Staplesc THINK: TB and HIV Investigative Network, Durban, South Africa

Nestani Tukvadzed TB Clinical Research Unit, National Centre for Tuberculosis and Lung Diseases, Tbilisi, GeorgiaView further author information

Gantsetseg Dorje TB Research and Surveillance Department, National Center for Communicable Diseases, Ulaanbaatar, MongoliaView further author information

Sindisiwe Zacac THINK: TB and HIV Investigative Network, Durban, South AfricaView further author information

Ekaterine Sanikidzef Davit Tvildiani Medical University, Tbilisi, GeorgiaView further author information

Nasanjargal Pureve TB Research and Surveillance Department, National Center for Communicable Diseases, Ulaanbaatar, MongoliaView further author information

Hanif Esmaila MRC Clinical Trials Unit at UCL, UCL, London, UK

Your download is now in progress and you may close this window